共 50 条
Heart Failure Specialist Care and Long-Term Outcomes for Patients Admitted With Acute Heart Failure
被引:0
|作者:
Cannata, Antonio
[1
,2
]
Mizani, Mehrdad A.
[3
]
Bromage, Daniel I.
[1
,2
]
Piper, Susan E.
[1
,2
]
Hardman, Suzanna M. C.
[4
]
Sudlow, Cathie
[3
]
de Belder, Mark
[5
]
Scott, Paul A.
[1
,2
]
Deanfield, John
[5
]
Gardner, Roy S.
[6
,7
]
Clark, Andrew L.
[8
]
Cleland, John G. F.
[9
]
Mcdonagh, Theresa A.
[1
,2
]
机构:
[1] Kings Coll London, British Heart Fdn Ctr Res Excellence, Fac Life Sci, Sch Cardiovasc Med, London, England
[2] Kings Coll Hosp NHS Fdn Trust, Cardiol Dept, London, England
[3] British Heart Fdn, Hlth Data Res United Kingdom, Data Sci Ctr, London, England
[4] Whittington Hlth, London, England
[5] Natl Inst Cardiovasc Outcomes Res NICOR, NHS Arden & Greater East Midlands Commissioning Su, Leicester, England
[6] Univ Glasgow, Inst Cardiovasc & Med Sci, BHF Cardiovasc Res Ctr, Glasgow, Scotland
[7] Golden Jubilee Natl Hosp, Scottish Natl Adv Heart Failure Serv, Clydebank, Scotland
[8] Hull Univ Teaching Hosp Trust, Kingston Upon Hull, England
[9] Univ Glasgow, British Heart Fdn, Sch Cardiovasc & Metab Hlth, Ctr Res Excellence, Glasgow, Scotland
基金:
英国医学研究理事会;
关键词:
COVID-19;
heart failure;
National Heart Failure Audit;
specialist care;
MORTALITY;
ASSOCIATION;
MANAGEMENT;
THERAPY;
D O I:
暂无
中图分类号:
R5 [内科学];
学科分类号:
1002 ;
100201 ;
摘要:
Background: For patients with acute heart failure (HF), specialist HF care during admission improves diagnosis and treatments. Objectives: The authors aimed to investigate the association of HF specialist care with in-hospital and longer term prognosis. Methods: The authors used data from the National Heart Failure Audit from January 1, 2018, to December 31, 2022, linked to electronic records for hospitalization and deaths. All-cause mortality was the primary outcome measure and in-hospital mortality the secondary outcome measure. Results: Data for 227,170 patients admitted to hospital with HF (median age: 81 years; IQR: 72-88 years), were analyzed. Approximately 80% of acute HF admissions received support from HF specialists. Thirty-nine percent of patients (n = 70,720) were seen by a multidisciplinary team (HF physicians and heart failure specialist nurses [HFSNs]), 22% (n = 40,330) were seen by HFSNs alone, and the remaining 39% (n = 71,700) were seen exclusively by specialist HF physicians. At discharge, more patients who received HF specialist care were prescribed medical therapy for HF and had specialized follow-up. Conversely, diuretic agents were prescribed to fewer patients. HF specialist care was independently associated with a higher rate of prescribing HF therapies at discharge and a lower likelihood of receiving diuretic therapy (OR: 0.90 [95% CI: 0.86-0.95]; P < 0.001). HF specialist care was associated with better long-term survival (HR: 0.89 [95% CI: 0.87-0.90]; P < 0.001) and lower in-hospital mortality (OR: 0.92 [95% CI: 0.0.88-0.97]; P < 0.001). Conclusions: Receiving HF specialist care during admission for HF is associated with a higher rate of implementation of medical therapy, fewer discharges on diuretic therapy, and lower in-hospital and long-term mortality across the left ventricular ejection fraction spectrum, especially for patients with heart failure with reduced ejection fraction. (c) 2025 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation. This is an open access article under the CC BY license (http://creativecommons. org/licenses/by/4.0/).
引用
收藏
页码:402 / 413
页数:12
相关论文